Array BioPharma Receives Milestone Payment From Amgen

Array BioPharma announced that it has received a $1,000,000 research milestone payment from Amgen Inc. The payment resulted from a drug discovery agreement initiated between Amgen and Array in January 2002. To date, Array has received $1,420,000 in total milestone payments from Amgen under this agreement. As part of the agreement, Array collaborated with Amgen on the discovery of proprietary lead compounds for an Amgen therapeutic target. Array would be entitled to further payments from Amgen should additional program milestones be achieved.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/05-10-2005/0003591968&EDATE=)